DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Francis J. Lunger sold 8,900 shares of the business’s stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $65.90, for a total transaction of $586,510.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at $67.55 on Friday. DENTSPLY SIRONA Inc. has a 52-week low of $52.53 and a 52-week high of $67.95. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.32 and a quick ratio of 1.59. The company has a market cap of $15,018.96, a P/E ratio of 26.05, a price-to-earnings-growth ratio of 2.59 and a beta of 1.27.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 EPS for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $978.99 million. During the same period in the prior year, the firm posted $0.66 EPS. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 2.66 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Insider Selling: DENTSPLY SIRONA Inc. (XRAY) Director Sells $586,510.00 in Stock” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/11/18/insider-selling-dentsply-sirona-inc-xray-director-sells-586510-00-in-stock.html.

Several institutional investors have recently modified their holdings of XRAY. Bank of Montreal Can boosted its holdings in shares of DENTSPLY SIRONA by 9.8% in the 2nd quarter. Bank of Montreal Can now owns 185,105 shares of the medical instruments supplier’s stock valued at $12,002,000 after buying an additional 16,557 shares in the last quarter. Gateway Investment Advisers LLC boosted its holdings in shares of DENTSPLY SIRONA by 8.4% in the 2nd quarter. Gateway Investment Advisers LLC now owns 19,408 shares of the medical instruments supplier’s stock valued at $1,258,000 after buying an additional 1,499 shares in the last quarter. Mn Services Vermogensbeheer B.V. boosted its holdings in shares of DENTSPLY SIRONA by 510.6% in the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 37,461 shares of the medical instruments supplier’s stock valued at $2,429,000 after buying an additional 31,326 shares in the last quarter. LS Investment Advisors LLC boosted its holdings in shares of DENTSPLY SIRONA by 2.9% in the 2nd quarter. LS Investment Advisors LLC now owns 13,375 shares of the medical instruments supplier’s stock valued at $867,000 after buying an additional 376 shares in the last quarter. Finally, Mountain Pacific Investment Advisers Inc. ID boosted its holdings in shares of DENTSPLY SIRONA by 1.3% in the 2nd quarter. Mountain Pacific Investment Advisers Inc. ID now owns 391,391 shares of the medical instruments supplier’s stock valued at $25,378,000 after buying an additional 5,020 shares in the last quarter. Institutional investors and hedge funds own 94.65% of the company’s stock.

A number of research firms have recently issued reports on XRAY. BidaskClub downgraded shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 16th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Friday, October 20th. Cleveland Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research note on Thursday, October 5th. Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price target on the stock in a research note on Monday, November 6th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $69.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Friday, October 6th. Three research analysts have rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $67.00.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Insider Buying and Selling by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.